Flash Sale 70% Off
Give customers details about the banner image(s) or content on the template.
Rare cannabinoids are the lesser-known compounds found in hemp in much smaller quantities than CBD. They are often called minor cannabinoids, but “minor” does not mean unimportant. These compounds help define the character of a full-spectrum extract and may shape how a formula feels, performs, and fits into a daily routine.
At True Hemp Science, we focus on botanically derived cannabinoids from the plant itself — especially CBDV, CBG, CBGA, CBDVA, and carefully selected full-spectrum blends. We do not build formulas around chemical conversion trends or novelty intoxicants. Our approach is rooted in whole-plant hemp, transparent formulation, and cannabinoid profiles that support the mind-body connection rather than overwhelm it.
What rare cannabinoids are
Rare cannabinoids vs minor cannabinoids
Botanical vs converted cannabinoids
CBDV and CBDVA
CBG and CBGA
THCV and THCVA
Botanical CBN
Comparison chart
FAQ
Rare cannabinoids are cannabinoids that occur naturally in hemp, but usually at much lower concentrations than CBD. In practical terms, “rare cannabinoids” often overlaps with “minor cannabinoids,” though the exact list can vary by cultivar, extraction method, and whether you are talking about raw precursor compounds or their decarboxylated counterparts.
For True Hemp Science, the rare cannabinoids most worth understanding are the ones that fit a whole-plant, botanical, non-converted philosophy:
CBDV
CBG
CBGA
CBDVA
THCV / THCVA
CBN (botanically derived)
These are the compounds are critical for the entourage effect and that help expand hemp beyond “just CBD” without turning the conversation into a race toward synthetic or heavily converted molecules.
The terms rare cannabinoids and minor cannabinoids are often used interchangeably.
A simple way to explain the difference:
Minor cannabinoids usually means cannabinoids present in smaller amounts than the dominant compounds in a plant.
Rare cannabinoids is the broader educational term for cannabinoids that consumers know less about, or that appear in lower abundance and require more intentional breeding, extraction, or preservation to work with effectively.
For most readers, the distinction is small. On this page, the two terms work together because they describe the same general category of lower-abundance cannabinoids found in hemp.
This is where True Hemp Science can stand apart.
Not every “rare cannabinoid” product is rare because the plant naturally expressed a meaningful amount of that compound. In today’s hemp market, some cannabinoids are sold primarily because they can be made through chemical conversion from more abundant hemp compounds. That is one reason the rare cannabinoid category has become confusing for consumers.
At True Hemp Science, we prefer botanical cannabinoids:
cannabinoids naturally expressed by the plant
cannabinoids preserved through careful extraction and formulation
varin compounds retained because they are part of the plant’s original chemistry
full-spectrum blends designed around real hemp profiles, not novelty conversions
A botanical-first approach gives you a cleaner story:
closer alignment with whole-plant hemp chemistry
better transparency in formulation
stronger continuity with a science-first education model
less dependence on trend-driven novelty compounds that can distract from long-term wellness positioning
One of the most overlooked parts of rare cannabinoid education is that many cannabinoids begin in raw precursor forms before heat or time transforms them.
That matters because cannabinoids such as CBGA and CBDVA are part of the plant’s original chemistry, not just end-stage finished compounds. Understanding that relationship helps explain why whole-plant formulation can look very different from chasing a single isolated cannabinoid.
For a deeper look at this side of hemp science, read our guide to Acidic Cannabinoids. You can also explore the Cannabinoid Compendium for a broader overview.
CBDV (cannabidivarin) is a naturally occurring cannabinoid related to CBD, but with a shorter side chain. It is non-intoxicating and appears in lower abundance than CBD in most hemp material.
CBDV is important because it expands the conversation beyond standard CBD formulations. It is often discussed in relation to:
clear-headed daytime formulas
differentiated cannabinoid blends
emerging neurological research
varin-rich hemp chemotypes
Search interest around CBDV benefits is growing, but the science should be presented carefully. The responsible summary is:
CBDV is non-intoxicating
it has attracted interest in neurological and receptor-level research
it remains a meaningful area of cannabinoid research
human evidence is still limited, so claims should stay conservative
We see CBDV as a rare cannabinoid that belongs in a functional botanical formula, especially when paired with other whole-plant compounds rather than stripped from context and marketed as a miracle molecule.
Explore CBDV-forward formulations in MoodiQ.
CBDVA (cannabidivarinic acid) is the precursor to CBDV — the raw, plant-made form that exists before decarboxylation. It belongs to the varin family of cannabinoids and is much less discussed than CBDV, largely because it occurs in lower abundance and has received far less research attention.
CBDVA matters because it reflects the plant’s original chemistry. For a company like True Hemp Science that works with raw and minimally altered formulas, CBDVA is not just a curiosity — it is part of a more complete hemp profile.
CBDVA is still under-researched. There is not enough clinical evidence to support strong benefits claims. But from a formulation and plant-science perspective, CBDVA is valuable because it:
represents the precursor state of CBDV
fits naturally into whole-plant formulations
supports a more faithful cannabinoid profile
CBG (cannabigerol) is often called the “mother cannabinoid,” although technically CBGA is the upstream precursor from which several cannabinoid pathways begin. CBG itself is the decarboxylated form and has become one of the most commercially important minor cannabinoids in hemp.
CBG may be more familiar than CBDV, but it still belongs in the minor-cannabinoid discussion because:
it occurs naturally in smaller amounts than CBD in most mature hemp
it is useful in daytime and clarity-oriented blends
it links the consumer-facing story of minor cannabinoids to the deeper plant-science story of CBGA
Shop the CBG Collection.
CBGA (cannabigerolic acid) is one of the foundational cannabinoids in hemp biosynthesis. It sits upstream of multiple cannabinoid pathways and helps explain how several other cannabinoids are formed.
CBGA matters because it helps explain:
why full-spectrum hemp chemistry starts earlier than finished neutral cannabinoids
why breeding, harvest timing, extraction, and storage all matter
why rare cannabinoid formulation is not only about chasing the end product
The cautious answer is that CBGA is scientifically interesting, but human clinical data remains limited. It is best presented as a foundational plant cannabinoid with emerging evidence, not as a fully proven wellness ingredient.
At True Hemp Science, CBGA is not just a chemistry term. It shows up in raw or minimally altered formulas such as LUMINA and helps illustrate the difference between whole-plant formulation and novelty cannabinoid marketing.
While this page focuses on rare cannabinoids, it is still useful to understand CBDa (cannabidiolic acid) because it is one of the most abundant cannabinoids produced by hemp.
CBDa is the precursor to CBD, meaning it exists naturally in raw hemp before heat converts it into CBD through decarboxylation.
Although CBDa itself is not rare, it helps explain how raw plant chemistry shapes the broader cannabinoid landscape.
THCV and THCVA are part of the broader rare-cannabinoid conversation because they are naturally occurring varin cannabinoids with distinctive chemistry and lower natural abundance than CBD-dominant compounds.
For this page, THCV should stay secondary to CBDV, CBG, CBGA, and CBDVA, but it still deserves a concise section because it helps complete the picture of how diverse natural hemp chemistry can be.
CBN (cannabinol) is a naturally occurring minor cannabinoid that forms as cannabinoids age and oxidize over time. Unlike cannabinoids that appear in high concentrations in fresh hemp plants, CBN typically develops through the natural transformation of other cannabinoids during storage, exposure to oxygen, or controlled processing.
Because of this transformation process, CBN is considered a rare cannabinoid and part of the broader category of minor cannabinoids found in hemp.
CBN has become widely known in hemp wellness formulas, particularly those designed for evening use, and it is increasingly included in full-spectrum cannabinoid blends.
Not all CBN is the same. In the hemp market, some CBN is presented as part of a botanical cannabinoid profile, while other CBN ingredients are created through more aggressive chemical conversion.
At True Hemp Science, we focus on botanical cannabinoids that remain connected to the plant’s natural chemistry. We view CBN as most meaningful when it fits within a whole-plant formulation strategy, not when it is treated as just another novelty ingredient.
Botanical CBN reflects natural cannabinoid transformation within hemp and belongs to a broader full-spectrum story. Converted CBN, by contrast, is typically produced through deliberate chemical manipulation of other cannabinoids.
That distinction is important to us. THS is committed to botanically derived cannabinoids, transparent formulation, and high-CBD, low-THC remedies designed to support balance rather than chase trends.
| Cannabinoid | Type | Botanical role | What to know | THS angle |
|---|---|---|---|---|
| CBDV | Neutral varin cannabinoid | Rare, non-intoxicating minor cannabinoid | Growing research interest; still early | Strong fit for functional daytime blends |
| CBDVA | Precursor cannabinoid | Raw precursor to CBDV | Very limited research; important in plant-first formulation | Fits whole-plant education |
| CBG | Neutral cannabinoid | Minor cannabinoid derived from CBGA | Increasingly familiar and versatile | Core collection and everyday functional use |
| CBGA | Precursor cannabinoid | Foundational upstream cannabinoid | Central to biosynthesis; human data still limited | Key THS differentiator |
| THCV / THCVA | Varin cannabinoids | Low-abundance cannabinoids with distinct chemistry | Useful for education breadth; keep claims conservative | Secondary support story |
| CBN | Minor cannabinoid | Often discussed in evening formulas | Source and pathway matter | Botanical CBN fits plant-based philosophy |
The rare cannabinoid category can go in two very different directions.
One path is to chase the newest converted molecule every few months.
The other is to study the plant more deeply.
True Hemp Science takes the second path.
We specialize in high-CBD, low-THC hemp remedies built around real cannabinoid architecture:
rare cannabinoids where they add value
CBDV and other varins where they belong
CBG and CBGA for foundational balance
botanical formulas that preserve the intelligence of the plant
That philosophy already shows up throughout the site in the Cannabinoid Compendium, the CBG Collection, and formulas like LUMINA, SOLARA, and MoodiQ.
Rare cannabinoids are naturally occurring cannabinoids found in hemp in smaller amounts than dominant compounds like CBD. They are often grouped with minor cannabinoids and may include CBDV, CBG, CBGA, CBDVA, THCV, and CBN.
In most consumer searches, the terms mean nearly the same thing. “Minor cannabinoids” is the more technical label, while “rare cannabinoids” is the more common educational phrase.
CBDV is generally described as non-intoxicating. It is structurally related to CBD, not THC.
CBDV is being studied for several potential applications, especially in neurological contexts, but human evidence remains limited. It is best discussed as a promising area of research rather than a proven treatment category.
CBGA is a foundational cannabinoid that sits upstream in cannabinoid biosynthesis. Multiple cannabinoid pathways begin from it.
CBDVA is the precursor to CBDV. It is one of the lower-abundance varin cannabinoids and remains much less studied than CBDV or CBD.
No. Some compounds sold under the rare cannabinoid label are largely made through chemical conversion rather than preserved from naturally expressed botanical profiles.
Our focus is on botanical cannabinoids and whole-plant formulations, not novelty conversion trends.